Trial ID or NCT#

NCT01789840

Status

not recruiting iconNOT RECRUITING

Purpose

The purpose of this study is to evaluate improvement of symptoms from benign prostatic hyperplasia (BPH) as assessed by the International Prostate Symptom Score (IPSS) for prostatic artery embolization (PAE) using Embosphere Microspheres compared to conventional transurethral resection of the prostate (TURP).

Official Title

Prospective, Controlled Investigation of Prostate Artery Embolization With Embosphere Microspheres Compared to Transurethral Resection of the Prostate for the Treatment of Symptomatic Benign Prostatic Hyperplasia

Eligibility Criteria

Ages Eligible for Study: 50 Years to 79 Years
Sexes Eligible for Study: Male
Accepts Healthy Volunteers: No

Investigator(s)

Harcharan Gill
Harcharan Gill
Urologic oncologist, Urologist, Genitourinary specialist
Kathryn Simmons Stamey Professor
Rajesh Shah
Rajesh Shah
Interventional radiologist
Clinical Associate Professor, Radiology
David Hovsepian, MD
David Hovsepian, MD
Interventional radiologist, Radiologist
Clinical Professor, Radiology
James D. Brooks
James D. Brooks
Surgical oncologist, Urologic surgeon
Keith and Jan Hurlbut Professor
John D. Louie, MD
John D. Louie, MD
Interventional radiologist
Clinical Associate Professor, Radiology
Daniel Sze, MD, PhD
Daniel Sze, MD, PhD
Interventional radiologist
Professor of Radiology (Interventional Radiology)

Contact us to find out if this trial is right for you.

CONTACT

Denise Haas
(650) 736-1252